Abstract
Cerebral sinovenous thrombosis (CSVT) is a rare and serious disorder that involves high morbi-mortality and neurological sequelae. Prognosis can be improved with an early diagnosis and an optimal treatment. Although anticoagulation is recommended, the treatment of CVST in children and neonates remains controversial. Noclinical trials are available on the safety and efficacy of anticoagulation in children.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
